Cymabay Therapeu Gross Profit vs. Revenue

CBAYDelisted Stock  USD 11.83  0.27  2.34%   
Based on Cymabay Therapeu's profitability indicators, Cymabay Therapeu may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Cymabay Therapeu's ability to earn profits and add value for shareholders.
For Cymabay Therapeu profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cymabay Therapeu to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cymabay Therapeu utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cymabay Therapeu's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cymabay Therapeu over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Please note, there is a significant difference between Cymabay Therapeu's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cymabay Therapeu is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cymabay Therapeu's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cymabay Therapeu Revenue vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Cymabay Therapeu's current stock value. Our valuation model uses many indicators to compare Cymabay Therapeu value to that of its competitors to determine the firm's financial worth.
Cymabay Therapeu is rated below average in gross profit category among its peers. It is rated third in revenue category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cymabay Therapeu's earnings, one of the primary drivers of an investment's value.

Cymabay Revenue vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Cymabay Therapeu

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
(41.63 M)
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Cymabay Therapeu

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
31.07 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Cymabay Revenue vs Competition

Cymabay Therapeu is rated third in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 434.5 Million. Cymabay Therapeu holds roughly 31.07 Million in revenue claiming about 7% of equities under Health Care industry.

Cymabay Therapeu Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Cymabay Therapeu, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cymabay Therapeu will eventually generate negative long term returns. The profitability progress is the general direction of Cymabay Therapeu's change in net profit over the period of time. It can combine multiple indicators of Cymabay Therapeu, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California. Cymabay Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Cymabay Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Cymabay Therapeu. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cymabay Therapeu position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cymabay Therapeu's important profitability drivers and their relationship over time.

Use Cymabay Therapeu in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cymabay Therapeu position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cymabay Therapeu will appreciate offsetting losses from the drop in the long position's value.

Cymabay Therapeu Pair Trading

Cymabay Therapeu Pair Trading Analysis

The ability to find closely correlated positions to Cymabay Therapeu could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cymabay Therapeu when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cymabay Therapeu - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cymabay Therapeu to buy it.
The correlation of Cymabay Therapeu is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cymabay Therapeu moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cymabay Therapeu moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cymabay Therapeu can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Cymabay Therapeu position

In addition to having Cymabay Therapeu in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Steel Works Etc Thematic Idea Now

Steel Works Etc
Steel Works Etc Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Steel Works Etc theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Steel Works Etc Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Consideration for investing in Cymabay Stock

If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities